877 research outputs found
Solar Power in the Garden State
No full textThis special issue on energy and solar power in New Jersey was made possible because of the extensive portfolio of research centers and institutes at the Edward J. Bloustein School of Planning and Public Policy. Dr. Frank A. Felder, an Associate Research Professor, has been director of the School’s Center for Energy, Economic & Environmental Policy (CEEEP) since 2006. Frank is a nuclear engineer with a PhD degree from MIT, and he, along with his CEEEP colleague, Shankar N. Chandramowli, coauthored the main article in this issue of the Advance & Rutgers Report. CEEEP has worked extensively with the New Jersey Board of Public Utilities on projects, including New Jersey’s current Energy Master Plan.Shining Brightly: Bloustein's Centers of Excellence / by James W. Hughes and Joseph S. Seneca -- Solar Power in the Garden States / by Shankar N. Chandramowli and Frank A. Felder.Guest contributors include Shankar N. Chandramowli and Frank A. Felder, PhD, Director—Center for Energy, Economic and Environmental Policy at the Edward J. Bloustein School of Planning and Public PolicyReports published as Issue Paper Number 5, May 2011, in Advance & Rutgers Report, Special Issue
Estimating catastrophic health expenditures: Need for improved methodology and interpretation
No full text
Universal Health Insurance in India: Ensuring equity, efficiency, and quality
No full textIndian health system is characterized by a vast public health infrastructure which lies underutilized, and a largely unregulated private market which caters to greater need for curative treatment. High out-of-pocket (OOP) health expenditures poses barrier to access for healthcare. Among those who get hospitalized, nearly 25% are pushed below poverty line by catastrophic impact of OOP healthcare expenditure. Moreover, healthcare costs are spiraling due to epidemiologic, demographic, and social transition. Hence, the need for risk pooling is imperative. The present article applies economic theories to various possibilities for providing risk pooling mechanism with the objective of ensuring equity, efficiency, and quality care. Asymmetry of information leads to failure of actuarially administered private health insurance (PHI). Large proportion of informal sector labor in India′s workforce prevents major upscaling of social health insurance (SHI). Community health insurance schemes are difficult to replicate on a large scale. We strongly recommend institutionalization of tax-funded Universal Health Insurance Scheme (UHIS), with complementary role of PHI. The contextual factors for development of UHIS are favorable. SHI schemes should be merged with UHIS. Benefit package of this scheme should include preventive and in-patient curative care to begin with, and gradually include out-patient care. State-specific priorities should be incorporated in benefit package. Application of such an insurance system besides being essential to the goals of an effective health system provides opportunity to regulate private market, negotiate costs, and plan health services efficiently. Purchaser-provider split provides an opportunity to strengthen public sector by allowing providers to compete
Role of health economics in developing efficient universal health care system
No full textApplication of economic principles can bring about a significant change in the performance of health system. An in-depth understanding of how to generate resources, how to pool funds, how to purchase health services and pay providers of health care, will affect how the health system delivers on its two important objectives, i.e. efficiency and equity. The economic underpinnings of health system are important structural and functional factors to aid in planning and delivery of health care services. Health economics can help in making informed decisions by explaining the factors that affect consumption and utilization of health services both from the demand and supply side using the principles of microeconomics. This is vital for improving the ‘coverage’ of all desired preventive and curative health care services. Most of the recent health system interventions such as increased public health subsidy, creating demand side financing mechanisms like conditional cash transfers schemes such as Janani Suraksha Yojana, performance based payments to Accredited Social Health Activist (ASHAs), incentivizing health workforce in rural and difficult areas, are all grounded in economic theories. Despite years of advocacy, resources have been and will continue to be scarce in health sector. On the contrary, demands for increasing the coverage of existing programs and introduction of newer interventions and technology are increasing. As a result hard choices need to be made for rational allocation of resources for maximizing the value of money spent. Despite a strong felt need among policy makers and program managers for health economists, there is an acute shortage of professionals who have requisite knowledge of health economics. This calls for introduction of health economics in the curriculum of medical and public health courses. Health professionals should also be encouraged to undertake research in this field of health economics and health financing
Interview with Scott Barretta, freelance researcher and author
No full textThis interview was conducted as a teaching interview to instruct field school participants in interviewing technique; Interviewer: Michael Taft, Recordist: Guha Shankar. Recorded at Barnard Observatory (University of Mississippi)
Contribution of Shankar Nighantu w.r.t. Vishahara Dravyas: A Review
No full textToxicity, which may be intentional, unintentional or accidental, is a grave problem throughout the world from ages. Advancements in the literature of Ayurveda address this problem by including the various treatments of toxicities, where Shankar Nighantu is one of them. Shankar Nighantu is a modern lexicon in Ayurvedic Materia Medica, originating in the 20th century and written by Shankar datta Gauda in the Hindi language. This lexicon based on Ayurvedic and Unani references, constructed in Hindi alphabetical order, is in three parts and contains vast information about the botanical characteristics, medicinal properties, and therapeutic indications of numerous plants, animals, and their products, as well as metals and minerals, aiding in the effective practice of this ancient healing tradition in contemporary times. Various Vishahara dravyas (Antivenom or Anti-toxic properties or Anti-poisonous drugs) are also listed highlighting the significance of toxicity treatment. Vishahara dravyas are elements that can prevent and eliminate toxins or poisons from the body. These elements play a crucial role in Ayurveda, which emphasises the importance of detoxification for maintaining health and treating diseases. Unani dravyas that are referred from ‘Makhjan’, are also mentioned as a unique entity as Vishahara property in this Nighantu. This Nighantu also includes various drugs used as folklore medicine. The author indicates various single drug as well as compound formulations to be used as antitoxic. Chuk, Hatthajodi, Chumbak patthar (Magnetic stone) are a few controversial and unexplored drugs that need further research for its antitoxic properties. This literary review aims to focus on the data found in Shankar Nighantu regarding various antitoxic drugs that is Vishahara dravyas. It will assist researchers and medical practitioners in gaining better insight about principle of treatment of toxicity
India’s Macroeconomic Performance and Policies since 2000
No full textThe paper reviews Indias macroeconomic performance and policies since 2000. The first section briefly summarizes key macroeconomic developments regarding economic growth, inflation, external balance, the fiscal situation and aggregate savings and investment. The second section considers some of the challenges posed to macroeconomic management in this period and the efficacy of the policy responses adopted. In particular, it analyses the progress in fiscal consolidation and the policies adopted to deal with the challenge of the unprecedented surge in external capital inflows into India. The final section outlines some of the major macro policy issues that need to be addressed in the years ahead, including : the resurgence of high fiscal deficits; the issues relating to external convertibility and exchange rate management; the role of the Reserve Bank of India in macroeconomic policy and coping with a weak international economic environment.economic growth, inflation, Fiscal Policy, savings and investment, Capital Inflows, exchange rate policy, central bank role
Impact and cost-effectiveness evaluation of nutritional supplementation and complementary interventions for tuberculosis treatment outcomes under mukti pay-for-performance model in Madhya Pradesh, India: A study protocol
No full textBackground: A “pay-for-performance” (P4P) intervention model for improved tuberculosis (TB) outcomes, called “Mukti,” has been implemented in an underdeveloped tribal area of central India. The target of this project is to improve nutritional status, quality of life (QoL), and treatment outcomes of 1000 TB patients through four interventions: food baskets, personal counseling, peer-to-peer learning and facilitation for linkage to government schemes. The current study aims to assess the success of this model by evaluating its impact and cost-effectiveness using a quasi-experimental approach. Methods: Data for impact assessment have been collected from 1000 intervention and control patients. Study outcomes such as treatment completion, sputum negativity, weight gain, and health-related QoL will be compared between matched samples. Micro costing approach will be used for assessing the cost of routine TB services provision under the national program and the incremental cost of implementing our interventions. A decision and Markov hybrid model will estimate long-term costs and health outcomes associated with the use of study interventions. Measures of health outcomes will be mortality, morbidity, and disability. Cost-effectiveness will be assessed in terms of incremental cost per quality-adjusted life-years gained and cost per unit increase in patient weight in intervention versus control groups. Results: The evidence generated from the present study in terms of impact and cost-effectiveness estimates will thus help to identify not only the effectiveness of these interventions but also the optimal mode of financing such measures. Our estimates on scale-up costs for these interventions will also help the state and the national government to consider scale-up of such interventions in the entire state or country. Discussion: The study will generate important evidence on the impact of nutritional supplementation and other complementary interventions for TB treatment outcomes delivered through P4P financing models and on the cost of scaling up these to the state and national level in India
- …
